| |
| |
|
| Insider
Information: |
Malik Fady Ibraham |
| Relationship: |
EVP Research & Develop... |
| City: |
South San Francisco |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
137,056 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$8,242,548 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
137,056 |
|
|
| Total
Value |
$8,242,548 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
6
|
|
Stock
price went up :
|
0
|
5
|
| Stock
price went down : |
0
|
1
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
5.0
|
| Percentage
Gain/Loss : |
0.0%
|
 409.8%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Cytokinetics Inc |
CYTK |
EVP Research & Develop... |
2024-05-07 |
137,056 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
118 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 5
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| CYTK |
Cytokinetics Inc |
SVP Research & Early DevOffice |
• – – |
2012-06-01 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
33,632 |
|
- |
|
| CYTK |
Cytokinetics Inc |
SVP Research & Early Dev |
• – – |
2012-09-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
87,500 |
121,132 |
0 |
- |
|
| CYTK |
Cytokinetics Inc |
SVP Research & Early Dev |
• – – |
2013-09-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
14,583 |
29,846 |
0 |
- |
|
| CYTK |
Cytokinetics Inc |
EVP Research & Development |
• – – |
2017-02-28 |
4 |
A |
$0.00 |
$55 |
D/D |
55,000 |
45,404 |
0 |
- |
|
| CYTK |
Cytokinetics Inc |
EVP Research & Development |
• – – |
2018-02-27 |
4 |
A |
$0.00 |
$40 |
D/D |
40,000 |
86,191 |
0 |
- |
|
| CYTK |
Cytokinetics Inc |
EVP Research & Development |
• – – |
2018-02-28 |
4 |
A |
$0.00 |
$25 |
D/D |
25,000 |
111,191 |
0 |
- |
|
| CYTK |
Cytokinetics Inc |
EVP Research & Development |
• – – |
2019-02-26 |
4 |
A |
$0.00 |
$0 |
D/D |
50,000 |
134,067 |
0 |
- |
|
| CYTK |
Cytokinetics Inc |
EVP Research & Development |
• – – |
2020-03-06 |
4 |
A |
$0.00 |
$0 |
D/D |
50,000 |
156,621 |
0 |
- |
|
| CYTK |
Cytokinetics Inc |
EVP Research & Development |
• – – |
2021-03-02 |
4 |
A |
$0.00 |
$0 |
D/D |
35,000 |
173,982 |
0 |
- |
|
| CYTK |
Cytokinetics Inc |
EVP Research & Development |
• – – |
2022-02-16 |
4 |
A |
$0.00 |
$0 |
D/D |
7,148 |
156,462 |
0 |
- |
|
| CYTK |
Cytokinetics Inc |
EVP Research & Development |
• – – |
2022-03-02 |
4 |
A |
$0.00 |
$0 |
D/D |
30,000 |
178,000 |
0 |
- |
|
| CYTK |
Cytokinetics Inc |
EVP Research & Development |
• • – |
2023-02-10 |
4 |
GD |
$0.00 |
$0 |
D/D |
150 |
152,439 |
0 |
- |
|
| CYTK |
Cytokinetics Inc |
EVP Research & Development |
• • – |
2023-03-06 |
4 |
A |
$0.00 |
$0 |
D/D |
40,000 |
175,183 |
0 |
- |
|
| CYTK |
Cytokinetics Inc |
EVP Research & Development |
• • – |
2024-03-14 |
4 |
A |
$0.00 |
$0 |
D/D |
21,333 |
142,567 |
0 |
- |
|
| CYTK |
Cytokinetics Inc |
EVP Research & Development |
• • – |
2024-04-12 |
4 |
GD |
$0.00 |
$0 |
D/D |
150 |
138,417 |
0 |
- |
|
| CYTK |
Cytokinetics Inc |
SVP Research & Early Dev |
• – – |
2012-09-04 |
4 |
D |
$0.76 |
$24,353 |
D/D |
(32,052) |
89,080 |
0 |
- |
|
| CYTK |
Cytokinetics Inc |
EVP Research & Development |
• – – |
2019-03-07 |
4 |
AS |
$5.98 |
$8,970 |
D/D |
(1,500) |
132,567 |
0 |
- |
|
| CYTK |
Cytokinetics Inc |
EVP Research & Development |
• – – |
2022-03-10 |
4 |
OE |
$6.00 |
$161,112 |
D/D |
26,852 |
194,936 |
0 |
- |
|
| CYTK |
Cytokinetics Inc |
EVP Research & Development |
• – – |
2022-04-07 |
4 |
OE |
$6.00 |
$138,888 |
D/D |
23,148 |
191,232 |
0 |
- |
|
| CYTK |
Cytokinetics Inc |
EVP Research & Development |
• – – |
2021-12-09 |
4 |
OE |
$6.30 |
$183,746 |
D/D |
29,166 |
172,053 |
0 |
- |
|
| CYTK |
Cytokinetics Inc |
EVP Research & Development |
• • – |
2024-02-06 |
4 |
OE |
$6.67 |
$190,795 |
D/D |
28,605 |
175,578 |
0 |
- |
|
| CYTK |
Cytokinetics Inc |
EVP Research & Development |
• • – |
2024-03-05 |
4 |
OE |
$6.67 |
$190,789 |
D/D |
28,604 |
167,577 |
0 |
- |
|
| CYTK |
Cytokinetics Inc |
EVP Research & Development |
• • – |
2024-04-09 |
4 |
OE |
$6.67 |
$190,795 |
D/D |
28,605 |
171,172 |
0 |
- |
|
| CYTK |
Cytokinetics Inc |
EVP Research & Development |
• • – |
2024-05-07 |
4 |
OE |
$6.67 |
$94,621 |
D/D |
14,186 |
152,603 |
0 |
- |
|
| CYTK |
Cytokinetics Inc |
EVP Research & Development |
• – – |
2018-11-01 |
4 |
AS |
$6.68 |
$10,020 |
D/D |
(1,500) |
88,567 |
0 |
- |
|
118 Records found
|
|
Page 1 of 5 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
